SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Food - Processing and Agriculture >

Plandai Biotechnology, Inc. (PLPL)

PLPL RSS Feed
Add PLPL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Aston Martin
Search This Board:
Last Post: 5/4/2015 4:22:29 AM - Followers: 178 - Board type: Free - Posts Today: 0


www.plandaibiotech.com

Movie by Plandai:
http://vimeo.com/95723836









Interview of CEO (Audio / February 14, 2012)
http://thestockradio.com/plpl-plandai-biotechnology-inc-v-p-global-director-of-marketing-sales-callum-baylis-duffield/

 
 

Security Details

 

Plandai Biotechnology, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, "PLPL". As such, Business, operational and financial information on PLPL is fully transparent and available to public view.  

www.otcmarkets.com

  A/S :        500 million confirmed / State of Nevada
  O/S :                134.300.000 (Febr. 6th, 2015)
Free Float:           66.300.000 (Febr. 6th, 2015)

Incorporated in: NV,USA - Year of Inc.:  2012

                                                                                                                                                                                                                   Transfer Agent

Signature Stock Transfer, Inc., Transfer Agent, 2632 Coachlight Ct., Plano, TX, 75093, 972-612-4120

SignatureStock@aol.com


http://www.anneslie.org/times/News_icon.jpg

                                                             Plandai Biotechnology, Inc.'s CEO Discusses Company's Plans for 2015____________________________________

NEW YORK, NY--(Marketwired - January 09, 2015) - Plandaí Biotechnology (PLPL) recently updated shareholders on a list of accomplishments reached in 2014, so Stock Market Media Group (SMMG), a research and content development investment relations firm, spoke with Plandaí's Chief Executive Officer, Roger Duffield, to discuss Plandaí's plans for 2015.

SMMG: First and foremost, can we get your reaction to the opening of your new production facility in South Africa and what does its completion mean for Plandaí in 2015?

Roger Duffield: "Well, opening the Senteeko facility is really the culmination of over a decade of research, sacrifice, and determination. Taking the initial concept that we could produce a highly bioavailable plant extract -- at a time when no one was even looking at the importance of bioavailability for nutraceuticals -- and then seeing it through to this point, has been an amazing journey that wouldn't have happened without the help and support of countless people. I get chills every time I visit Senteeko, drive thirty minutes on logging roads through thick forests, and then pass the gates to our estate and see the vast acres of tea with this amazing jewel of a factory sitting in the middle. I'm overwhelmed, excited, relieved, and deeply humbled all at the same time." 

SMMG: What is the significance of Plandaí's shift from a research and development company to a biotech that produces and sells products?

Roger Duffield: "Let me answer by first stating that Plandaí will always be a research and development company. When you look at the pharmacopeia of medicinal plants, you can see that there are hundreds of potential future research products for us. And even with just green tea catechins, we could spend a lifetime just on different human clinical trials as we explore the vast potential of this amazing plant.

"But, from a practical standpoint, now that the factory is opened, we can start generating revenues and positive cash flows. This will allow us to operate without dilution or incurring additional debt, expand our products lines, and return value to our shareholders. "Operationally, it means that we now have a whole new business model with new logistics. When you stop to think about what it takes to sell a product like Phytofare®, it requires so many moving parts working in harmony. Growing the leaf, picking it properly, manufacturing, batch testing, packaging, tracking and quality control, shipping, customs. Then you have the sales aspect, which includes marketing, trade shows, literature. It's really quite a process that I think few people fully understand."

SMMG: In 2013 Plandaí announced its entrance into the cannabis research arena, in 2014, the company secured a licensing agreement with Diego Pellicer and then obtained a consent letter from the Minister of Health in Uruguay to begin growing cannabis and producing an extract for animal testing, so what can we expect in 2015?

Roger Duffield: "Our plan at this point is to establish the cannabis growing infrastructure in Uruguay this year with an expectation of having an extract ready for testing six to nine months after it comes online. Our initial goal of having a product market-ready by the end of 2014 proved unrealistic once we determined that current U.S. laws, even in states where marijuana is legalized, prohibited us from legally acquiring cannabis, producing an extract, and then testing it inside the U.S. "Our operation in Uruguay will allow us to better control the chemical profile and then conduct our research into various neural disorders in a safe, legal, and scientifically validated manner. Also, we will be able to establish standards for dosage and chemical profile, which has so far been very limited with respect to cannabis research."

SMMG: After releasing the data in 2014 from a human clinical trial performed at North West University in South Africa that showed Plandaí's Phytofare® Catechin Complex demonstrated ten times greater bioavailability over a generic catechin extract, what is next in the on-going research at North West University?

Roger Duffield: "Starting this month, the research team at North West University in South Africa, under the supervision of the Dean's office of the Faculty of Health Sciences and the inventor of the Pheroid® delivery system, Prof. Anne Grobler, will complete the third arm of the bioavailability study. This final phase will use the same 26 human subjects, but this time the study will incorporate the addition of Pheroid® to the Phytofare® extract. "We anticipate that adding the Pheroid® delivery system will increase the overall bioavailability while also opening up the potential to use our extracts in less controlled applications such as adding Phytofare® to other ingredients including topical creams and liquids, and in environments where you are less able to control exposure to outside influences such as UV light, which kills the antioxidants."North West University will also be conducting our human weight loss clinical trial, which will test the Phytofare® versus a placebo over 90 days and involving 120 patients. This trial will also be looking at a complete blood panel so we can identify from a medical standpoint the effects of catechins on everything from blood sugar to cholesterol. The results could potentially open entirely new fields of research."

SMMG: Any closing thoughts?

Roger Duffield: "2015 promises to be a productive year for Plandaí. With the completion of the new laboratory inside the Senteeko facility, we plan to produce our first citrus extract and then test its bioavailability followed by a human clinical trial to confirm improved respiratory benefits including symptom relief for sinus, colds and the flu. And, as always, we continue to explore the medical potential of other phytonutrients and expect to test new extracts throughout the year."

______________________________________________________________________________________________________________________________________________________________________________________________

For press releases please visit: www.plandaibiotech.com/press-release.html

_____________________________________________________________________________________________________________________________________________________________________________________________
 

                                                                                                                                                    PLANDAI BIOTECHNOLOGY at Africa                                                 

 

          


          

 

                                                                                                              Management Team
Roger Duffield President, Chief Executive officer and member of the Board of Directors

Callum Baylis-Duffield Vice-President and Global Director: Marketing Sales

David Rzepnicki Chief Financial Officer and member of the Board of Directors

Tim Matula Investor Relations and member of the Board of Directors

Contact:
Roger Duffield
Chief Executive Officer
Plandai Biotechnology, Inc.
1451 North 200 East, Suite 130C
Logan, UT 9810

(Validity unkown:
Corporate Headquarters Address: 2226 Eastlake Ave E, #156 Seattle, Washington, 98102, USA
Phone: (425) 466-0212
Website:              http://www.plandaibiotech.com
Email:                  Info@plandaibiotech.com

 

http://www.pub.ac.za/newsletter/02-201412/img/p-article-1-E.jpg http://www.plandaibiotech.com/blog/wp-content/uploads/2013/05/7.jpg http://www.plandaibiotech.com/blog/wp-content/uploads/2012/09/2012-08-26-12.46.231.jpg
http://www.otcjournal.com/otcb/wp-content/uploads/2013/09/factory.gif
http://www.plandaibiotech.com/blog/wp-content/uploads/2014/02/senteeko-2.jpg
http://www.plandaibiotech.com/images/senteeko-2014-02.jpg




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PLPL
Current Price
Volume:
Bid Ask Day's Range
Wiki
PLPL News: Current Report Filing (8-k) 04/28/2015 06:07:39 AM
PLPL News: Notice of Effectiveness (effect) 02/13/2015 06:01:43 AM
PLPL News: Securities Registration Statement (simplified Form) (s-3/a) 02/09/2015 05:18:41 PM
PLPL News: Securities Registration Statement (simplified Form) (s-3) 01/21/2015 04:28:14 PM
PLPL News: Quarterly Report (10-q) 11/14/2014 04:20:07 PM
PostSubject
#12186   Sorry, if you can not connect the news Aston Martin 05/04/15 04:22:28 AM
#12185   I said: "If you're talking about the Diego tradetrak 05/01/15 09:56:09 PM
#12184   Where do I write about Diego Pellicier accountant Aston Martin 05/01/15 04:06:44 AM
#12183   Okay. I thought, for a change, you might tradetrak 04/30/15 10:17:16 PM
#12182   New auditor - guess why - the truth Aston Martin 04/28/15 12:14:46 PM
#12181   Do I get this right: Homepage of Plandai Aston Martin 04/21/15 10:51:37 AM
#12180   You obvioulsy do not care at all how Aston Martin 04/21/15 04:07:16 AM
#12179   Re: Plandai will sign offtake but under a tradetrak 04/20/15 08:05:13 PM
#12178   Yep. Happy to discuss both good and bad tradetrak 04/20/15 07:56:12 PM
#12177   I don't know where you're getting your #s tradetrak 04/20/15 07:53:48 PM
#12176   Well, dilution must not be the worst...if you Aston Martin 04/20/15 09:08:46 AM
#12175   Happy to discuss all the good and bad, riberyknuckles 04/20/15 04:42:00 AM
#12174   I think that the only way a CEO riberyknuckles 04/20/15 04:40:19 AM
#12173   LOL. You just can't help yourself, Aston, can you? tradetrak 04/19/15 09:28:18 PM
#12172   just like to add: To me it makes Aston Martin 04/18/15 03:44:16 PM
#12171   Well said, my friend. Thanks. tradetrak 04/17/15 11:36:51 PM
#12170   ok, r-knuckles, that's a fair post! As Aston Martin 04/17/15 01:45:34 PM
#12169   Look, I don't want to get into a riberyknuckles 04/17/15 11:38:53 AM
#12168   Friends, maybe you read negative news also a Aston Martin 04/17/15 09:54:46 AM
#12167   The offtake will happen in one of two riberyknuckles 04/17/15 04:07:04 AM
#12166   Yes. Re: <<Perhaps some news of some type tradetrak 04/16/15 10:44:08 PM
#12165   Thanks, Ribery. It's great to hear a fresh tradetrak 04/16/15 10:37:05 PM
#12164   Good points all around, but I do believe bishmac 04/16/15 01:37:47 PM
#12163   Absolutely no arguments here. Maybe I didn't make riberyknuckles 04/16/15 11:32:29 AM
#12162   The reason for the drop could be also Aston Martin 04/16/15 11:22:17 AM
#12161   Well, sorry, this argument 'past is past' I Aston Martin 04/16/15 11:16:08 AM
#12160   someone used the video to dump big time tmonkey 04/16/15 04:29:44 AM
#12159   In my opinion, and purely my opinion, the riberyknuckles 04/16/15 03:53:11 AM
#12158   The machines and the factory are still too Aston Martin 04/16/15 02:36:57 AM
#12157   Yeah the video was great but .... They did brandao 04/16/15 01:40:57 AM
#12156   Very bad reaction today to a 'great' Aston Martin 04/15/15 06:15:14 PM
#12155   a video is just a video - real Aston Martin 04/15/15 01:01:18 PM
#12154   the video is great ! I think we foreveralone 04/15/15 10:42:35 AM
#12153   However, confidence suffers! Unpleasent but understandable. We will Aston Martin 04/15/15 10:42:22 AM
#12152   Great promotional video and GREAT farm & facility. tradetrak 04/14/15 10:07:42 PM
#12151   Well, nice video - no question. But I Aston Martin 04/14/15 05:15:04 PM
#12150   Here is the new video. I have visited riberyknuckles 04/14/15 09:00:35 AM
#12149   plandai to release latest video 4-14 labner 04/13/15 12:36:33 PM
#12148   MUST READ and LISTEN Aston Martin 04/11/15 06:05:39 AM
#12147   I have an ongoing worse feeling with PLPL. Aston Martin 04/11/15 05:47:41 AM
#12146   I would be happy already with a proper Aston Martin 04/08/15 06:12:07 PM
#12145   to be honest I am still very salty foreveralone 04/08/15 06:28:26 AM
#12144   LETS GET ON IT lets take PLPL to foreveralone 04/08/15 06:26:44 AM
#12143   Diego Pellicer is not Plandai Biotech - but Aston Martin 03/31/15 01:22:09 PM
#12142   Just an FYI ,,,,,Interesting that it says, "The Getitgogone 03/31/15 05:17:00 AM
#12141   Woops lol here * brandao 03/24/15 08:40:44 PM
#12140   Hopeless hear unfortunately. brandao 03/24/15 08:39:30 PM
#12139   Something very strange: Those, who are running a Aston Martin 03/24/15 11:41:01 AM
#12137   As I said: Forget chart technique here. Worthless. Aston Martin 03/18/15 01:31:11 PM
#12136   well, simply said, just a pity to notice Aston Martin 03/18/15 01:30:08 PM
PostSubject